Nutraceuticals for a heathy future
Hypha Wellness Jamaica is a company dedicated to the cultivation, extraction and manufacturing of nutraceuticals, mushrooms and standardised mushroom products. We are uniquely positioned to explore and optimise the therapeutic and commercial potentials of psilocybin and other fungi for local and international markets.
MycoMeditations is one of the world’s leading psychedelic retreat experiences that combines three high-dose psilocybin sessions with private and group therapy for powerful healing. Our retreats take place in serene locations and incorporate a safe, caring, facilitated group experience to catalyze life-changing transformations for our guests.
In our pursuit of a gold-standard retreat model, we have reviewed and adapted the best practices for psychedelic-assisted therapy from prestigious research institutes such as Johns Hopkins University and Imperial College London. Combining this with beautiful natural environments, we offer a way to explore legal psilocybin-assisted therapy that is evidence-based and highly effective.
Informed by nature and guided by science, Psyence is a life science biotechnology company pioneering the use of natural psilocybin to heal psychological trauma and the diagnosable disorders that can result: anxiety, depression, PTSD, stress, grief and bereavement. We have a focus on these conditions in the context of palliative care.
We are focused on the scientific research and development of psilocybin medical products for research institutions, clinics and regulatory-compliant psilocybin containing products. We are also developing nutraceutical products for depression, acute anxiety and sleep disorders.
With more than twenty years experience in mushroom cultivation Psacred Therapeutics specializes in the production of psilocybin, therapeutic and edible mushrooms for research, retreats, and legal sale to the wellness and culinary community.
We have a unique combination of business lines that provide a diverse, future-proof company by leveraging our first-mover advantage to commercialize with broad, immediate revenue stream potential. We are generating revenue now with an expansive near-term revenue plan growing an already robust portfolio of revenue lines while bridging modern science and indigenous traditions. Services provided in two countries and global product distribution/licensing partnerships give us the broadest footprint in the industry.
Our Executive Committee
Winston De La Haye,
M.D., M.P.H., D.M., I.C.A.P. | Chairman
Dr. Winston De La Haye is a Senior Lecture in Psychiatry at UWI, Mona, former Deputy Dean in the Faculty of Medical Sciences and Consultant Addiction and General Psychiatrist at the University Hospital of the West Indies. He completed his MD at the University of Pecs in Hungary, his Postgraduate Degree in Psychiatry at the UWI, his Masters in Public Health and Fulbright Fellowship in Substance Abuse at The Johns Hopkins University.
Dr. De La Haye established the Medicinal Cannabis Unit in the Ministry of Health in 2017, supervising the registration of 82 medicinal cannabis products in Jamaica. He is the Medical Director of the Aion Inernational Psychedlic Psychiatry Centre in Jamaica.
A former Captain in the Jamaica Defense Force, Dr. De La Haye is a Founding Member and Chairman of the Caribbean Psychedelics Association.
Dr. Tamika Haynes-Robinson | Chairwoman
Tamika Haynes-Robinson is a Neuropsychologist specializing in Traumatic Brain Injury, Stroke and Epilepsy. She completed an accelerated MSc. in cognitive science at the University of Birmingham in England where she conducted research in movement disorders on behalf of NASA at the Human movement and balance unit in Queens Square, London, England. She completed two post-doctoral fellowships in Neuropsychology at Emory University in Atlanta, Georgia and Yale University, New Haven, Connecticut.
She is currently conducting studies on the effects of psilocybin assisted group psychotherapy for major depression, anxiety and PTSD with Psyence.
She conducts neuropsychology clinics in Jamaica, Belize and the USA. Additionally, she has a wealth of expertise and experience in the mental health systems across the Caribbean and is an internationally renowned expert witness in mental health in Canada, the USA and England.
Justin Townsend | Chairman Retreats & Clinics Committee
With experience as an advisor to start-ups, most recently in the health care space, Justin brings a blend of business acumen, leadership skills and a nose for futuristic health models to the MycoMeditations team.
Throughout his career Justin has worked as a business leader across a range of industries, helping innovative companies identify opportunities, communicate their vision and deliver profitable products. But he has also been on a personal quest to explore alternative healing therapies to combat his own anxiety and depression.
Over the past 20 years Justin has delved into both transpersonal and Jungian depth psychology, explored psychedelic modes of healing and developed meditation and breath work techniques, which he taught in Germany.
With experience as an advisor to start-ups, most recently in the health care space, Justin brings a blend of business acumen, leadership skills and a nose for futuristic health models (as the CEO of)the MycoMeditations team.
Under Justin’s leadership at MycoMeditations has successfully brought psilocybin-assisted therapy to in excess of 1300 retreat participants.
Dr. Amza Ali | Chairman Science Committee
Dr Ali trained in Medicine at the University of the West Indies, Mona, with post-graduate
training in Internal Medicine at UWI (DM). After being awarded a British Commonwealth
Scholarship, he then trained in Neurology at the National Hospital for Neurology and
Neurosurgery, Queen Square, London, England with a research Fellow’s position in the
Retrovirus Research Group at the Clinical Research Centre, Harrow, England. He became a
member (MRCP, 1990) and Fellow (FRCP, 2003) of the Royal College of Physicians, London
and is specialist certified in Neurology by the Federation of Royal Colleges of Physicians of
the United Kingdom and the Association of British Neurologists. In 2001 he completed a
clinical fellowship in Epilepsy in New York at the Comprehensive Epilepsy Center,
Neurological Institute, Columbia Presbyterian Medical Center at Columbia University and is
board certified in Advanced Central Clinical Neurophysiology by the American Board of
Clinical Neurophysiology (ABCN). He was elected a Fellow of the American Academy of
Neurology (AAN) in 2013 and a Fellow of the American Epilepsy Society (AES) in 2018.
In 2001, he launched the Jamaican League Against Epilepsy (JLAE) and later transformed
the JLAE into the larger regional organization, the Epilepsy Society of the Caribbean (ESC), a
powerful advocacy platform for epilepsy. He has received several awards for his work,
including the Donald M. Palatucci Award for Neurology in 2009 from the American Academy
of Neurology. In 2011 he was recognised by Yale University with the Swebilius Lectureship
and Award for his “lasting achievements in the field of epilepsy”. His work has been
featured in Neurology Today, the official organ of the American Academy of Neurology
(AAN). In 2011 and again in 2012 he was chosen as AAN Ambassador to the Caribbean
region. In 2015 he was honoured by the Association of Consultant Physicians of Jamaica
(ACPJ) for his local, regional and international work in Neurology and Epilepsy. In March
2017 he was selected, as one of 3 physicians globally, for the International Award for
Excellence in Patient Care from the Royal College of Physicians of London, UK. In June 2019
he was awarded the title of lifetime Ambassador for Epilepsy by the International Bureau
for Epilepsy (IBE) and the International League Against Epilepsy (ILAE), the first time this
honour has been conferred on a physician of Caribbean origin.
Dr. Lorenzo Gordon
Dr. Lorenzo Gordon, MD, PhD is a Diabetologist, Consultant in Internal Medicine and a Biochemist. He is the current Dean and Medical Director of the Caribbean School of Medical Sciences, Jamaica (CSMSJ) and a lecturer at the University of the West Indies. Dr. Gordon is a graduate of the University of the West Indies, Mona where he holds a Doctor of Philosophy in Biochemistry as well as a medical degree from the Higher Institute of Medical Sciences of Havana, Cuba. He is a member of the European Association for the Study of Diabetes and has a private consulting practice in General Practice and Diabetology. He has over 50 peer-reviewed publications and is a founding member of the West Indies Immunology Society.
Dr. Gordon is a Clinical Research Specialist who specializes in cannabis-related and psilocybin related product research and development. He currently serves as a member of the Medicinal Cannabis Unit (MCU) Advisory Board Committee, Ministry of Health, Advisor to the Cannabis Licensing Authority (CLA) and Advisor to the Ministry of Health on Psychedelic mushrooms regulations and regulation of Psilocybin.
Douglas Gordon | Chairman Membership Committee
Douglas has almost 30 years work experience spanning finance, media, sales and marketing. He began his career in commercial banking with Bank of America before pursuing entrepreneurial ventures that shaped the next 20 years of his career. He is a visionary leader with a natural ability to look beyond the clutter and inspire others towards long term goals.
In 2016, he founded CanEx Jamaica - the premier Cannabis Business Conference & Expo that takes place in the Caribbean. The conference celebrated 3 years in 2018 with 1500 attendees from 23 countries and over 60 speakers, including keynotes from some of the top industry leaders across the globe. In the three years in which he has been a part of this burgeoning industry, he has spoken at events in Jamaica, Toronto, Washington DC, Mexico City, Trinidad & Tobago and Medellin, Colombia and forged a wide global network with special attention to developing business opportunities in the Caribbean and LATAM.
He serves as Chairman of Zimmer & Co. a medicinal cannabis and hemp- based CBD health and wellness distribution business, since its inception in 2017, where he inspires and leads the team to new markets and opportunities.
Kynan Cooke | Chairman Cultivation Committee
Benjamin Graeme
Benjamin Graeme, Director of Development at the Jamaica Cancer Care & Research Institute (JACCRI), is focused on generating awareness and resources in support of JACCRI’s mission. He is also founder and CEO of Jamaica Ingredients & Extracts, a CBD and natural product producer, and a co-founder and director of Hypha Wellness Jamaica Psilocybin. Benjamin’s mission is to develop profitable, efficient and sustainable businesses that take a holistic view of food and agriculture systems, recognizing the interconnectedness of the supply chain and identifying the economic, social, and environmental opportunities that come through those connections. His work with JACCRI underscores his interest in a comprehensive, scientific approach to health and wellness.
Dingle Spence, BSc., MBBS, Dip. Pall. Med, FRCR
Dingle Spence, BSc., MBBS, Dip. Pall. Med, FRCR, is a Jamaican physician with training in both Clinical Oncology and Palliative Medicine. She is the Senior Medical Officer of the Hope Institute Hospital, Jamaica’s only dedicated Oncology and Palliative Care unit. Dr Spence is an Associate Lecturer at the University of the West Indies, Mona, and is co-founder and co-director of the Jamaica Cancer Care and Research Institute (JACCRI), a nonprofit organization dedicated to improving the quality of cancer care and palliative care in Jamaica and the Caribbean. Dr Spence is also a Board Member of the International Association for Hospice and Palliative Care (IAHPC), and sits on the advisory boards of End Well and the Global Wellness Institute. Dr Spence has training in Traditional Chinese Medicine (acupuncture), homeopathy, Vortex healing, Reiki, and Shamanic Energy Medicine. She is also a trained psychedelic guide and has research interests in the use of plant- based medicines such as cannabinoids and psychedelics for holistic symptom relief for people with palliative care needs.
